$MBRX News Article - Moleculin Presents Positive P
Post# of 62
(Total Views: 62)
Posted On: 11/06/2023 11:45:46 AM
$MBRX News Article - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinical Trial Demonstrating 64% Stable Disease Rate Through Two Cycles of Annamycin for the Treatment of Soft Tissue Sarcomas (STS) Lung Metastases https://marketwirenews.com/news-releases/mole...49897.html
(0)
(0)Moleculin Biotech, Inc. (MBRX) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼